[SIME] YoY Annualized Quarter Result on 31-Mar-2022 [#3]

Announcement Date
24-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2022
Quarter
31-Mar-2022 [#3]
Profit Trend
QoQ- -5.34%
YoY- -32.04%
View:
Show?
Annualized Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 64,452,000 46,669,333 42,374,666 44,188,000 37,484,000 35,777,333 33,670,666 11.41%
PBT 2,377,333 1,421,333 1,656,000 2,261,333 1,318,666 1,262,666 965,333 16.19%
Tax 2,126,666 -253,333 -448,000 -529,333 -406,666 -185,333 1,549,333 5.41%
NP 4,504,000 1,168,000 1,208,000 1,732,000 912,000 1,077,333 2,514,666 10.19%
-
NP to SH 4,289,333 1,114,666 1,100,000 1,618,666 857,333 1,018,666 2,341,333 10.60%
-
Tax Rate -89.46% 17.82% 27.05% 23.41% 30.84% 14.68% -160.50% -
Total Cost 59,948,000 45,501,333 41,166,666 42,456,000 36,572,000 34,700,000 31,156,000 11.51%
-
Net Worth 1,915,295,960 15,881,279 15,935,208 15,645,835 14,283,039 14,485,788 14,145,745 126.43%
Dividend
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Div 27,264,000 272,640 363,195 544,202 181,371 181,355 181,355 130.41%
Div Payout % 635.62% 24.46% 33.02% 33.62% 21.16% 17.80% 7.75% -
Equity
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Net Worth 1,915,295,960 15,881,279 15,935,208 15,645,835 14,283,039 14,485,788 14,145,745 126.43%
NOSH 6,812,157 6,812,157 6,809,918 6,802,537 6,801,447 6,800,839 6,800,839 0.02%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 6.99% 2.50% 2.85% 3.92% 2.43% 3.01% 7.47% -
ROE 0.22% 7.02% 6.90% 10.35% 6.00% 7.03% 16.55% -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 9.46 684.70 622.25 649.58 551.12 526.07 495.10 -48.26%
EPS 62.93 16.27 16.13 23.73 12.67 14.93 34.40 10.58%
DPS 4.00 4.00 5.33 8.00 2.67 2.67 2.67 6.96%
NAPS 2.81 2.33 2.34 2.30 2.10 2.13 2.08 5.13%
Adjusted Per Share Value based on latest NOSH - 6,809,918
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 946.13 685.09 622.04 648.66 550.25 525.20 494.27 11.41%
EPS 62.97 16.36 16.15 23.76 12.59 14.95 34.37 10.60%
DPS 400.23 4.00 5.33 7.99 2.66 2.66 2.66 130.44%
NAPS 281.1585 2.3313 2.3392 2.2968 2.0967 2.1265 2.0765 126.43%
Price Multiplier on Financial Quarter End Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 29/03/24 31/03/23 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 -
Price 2.60 2.15 2.40 2.40 1.69 2.23 2.64 -
P/RPS 27.50 0.31 0.39 0.37 0.31 0.42 0.53 93.01%
P/EPS 413.16 13.15 14.86 10.09 13.41 14.89 7.67 94.21%
EY 0.24 7.61 6.73 9.91 7.46 6.72 13.04 -48.58%
DY 1.54 1.86 2.22 3.33 1.58 1.20 1.01 7.27%
P/NAPS 0.93 0.92 1.03 1.04 0.80 1.05 1.27 -5.05%
Price Multiplier on Announcement Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 23/05/24 24/05/23 24/05/22 25/05/21 21/05/20 29/05/19 25/05/18 -
Price 2.90 2.12 2.25 2.21 2.02 2.29 2.76 -
P/RPS 30.67 0.31 0.36 0.34 0.37 0.44 0.56 94.75%
P/EPS 460.83 12.96 13.93 9.29 16.03 15.29 8.02 96.31%
EY 0.22 7.71 7.18 10.77 6.24 6.54 12.47 -48.94%
DY 1.38 1.89 2.37 3.62 1.32 1.16 0.97 6.04%
P/NAPS 1.03 0.91 0.96 0.96 0.96 1.08 1.33 -4.16%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment